Cargando…
Real-World Evidence From More Than 1000 Patients Treated With Adalimumab For Moderate-to-Severe Psoriasis in the Czech Republic
INTRODUCTION: The study aimed to evaluate the real-world effectiveness of adalimumab as well as investigate the persistence of treatment and identify factors, which may affect it. METHODS: More than 1150 patients (4363.1 patient-years) with psoriasis who had been treated with adalimumab since the st...
Autores principales: | Kojanova, Martina, Cetkovska, Petra, Strosova, Daniela, Fialova, Jorga, Arenberger, Petr, Dolezal, Tomas, Gkalpakiotis, Spyridon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8018917/ https://www.ncbi.nlm.nih.gov/pubmed/33666877 http://dx.doi.org/10.1007/s13555-021-00499-8 |
Ejemplares similares
-
Risankizumab for the Treatment of Moderate-to-Severe Psoriasis: Real-Life Multicenter Experience from the Czech Republic
por: Gkalpakiotis, Spyridon, et al.
Publicado: (2021) -
Long-Term Efficacy, Safety, and Drug Survival of Guselkumab in Patients with Psoriasis: Real-World Data from the Czech Republic BIOREP Registry
por: Hugo, Jan, et al.
Publicado: (2023) -
Adalimumab Biosimilar-Induced Severe Paradoxical Palmoplantar Pustulosis in a Patient with Psoriasis and Psoriatic Arthritis Successfully Treated with Ixekizumab
por: Gkalpakiotis, Spyridon, et al.
Publicado: (2022) -
Isolated Melanocytic Hyperpigmentation of the Distal Digits – A Case Report and Review of the Literature
por: Marques, Emanuel C., et al.
Publicado: (2022) -
Unusual Periungual Nodulocystic Lesions Leading to the Diagnosis of Extranodal Marginal Zone Lymphoma
por: Gkalpakiotis, Spyridon, et al.
Publicado: (2020)